Literature DB >> 14690169

Histone acetylation and cancer.

Gregory Kouraklis, Stamos Theocharis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14690169     DOI： 10.1080/02841860310010664

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  5 in total

1.  Histone H4 N-terminal acetylation in Kasumi-1 cells treated with depsipeptide determined by acetic acid-urea polyacrylamide gel electrophoresis, amino acid coded mass tagging, and mass spectrometry.

Authors:  Liwen Zhang; Xiaodan Su; Shujun Liu; Amy R Knapp; Mark R Parthun; Guido Marcucci; Michael A Freitas
Journal:  J Proteome Res       Date:  2007-01       Impact factor: 4.466

Review 2.  Current evidence for histone deacetylase inhibitors in pancreatic cancer.

Authors:  Ioannis Koutsounas; Constantinos Giaginis; Efstratios Patsouris; Stamatios Theocharis
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

Review 3.  Histone deacetylase inhibitors and pancreatic cancer: are there any promising clinical trials?

Authors:  Ioannis Koutsounas; Constantinos Giaginis; Stamatios Theocharis
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

Review 4.  Molecular targets of aspirin and cancer prevention.

Authors:  L Alfonso; G Ai; R C Spitale; G J Bhat
Journal:  Br J Cancer       Date:  2014-05-29       Impact factor: 7.640

5.  HDAC1 promoted migration and invasion binding with TCF12 by promoting EMT progress in gallbladder cancer.

Authors:  Junyi He; Sheng Shen; Weiqi Lu; Yuhong Zhou; Yingyong Hou; Yong Zhang; Ying Jiang; Houbao Liu; Yebo Shao
Journal:  Oncotarget       Date:  2016-05-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.